Figure 1 from PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer

<p>Induction of EMT-like phenotype and metabolic switch in PDAC cells upon starvation. <b>A,</b> Representative images illustrating morphologic changes for PDAC-354 cells in response to treatment for 72 hours with the complex I inhibitor metformin (3 mmol/L), the β-oxidation inhibitor etomoxir (20 μmol/L), the complex II inhibitor malonate (5 mmol/L), the pyruvate carrier inhibitor UK5099 (100 μmol/L), or tumor-like conditions [low pH (HCl 50 μmol/L) + low glucose (1 mmol/L) + 3%O<sub>2</sub>]. Scale bar, 50 μm. <b>B,</b> Expression of EMT-associated genes (<i>ZEB1</i>, <i>SNAI1</i>, <i>SNAI2</i>, <i>LOXL2</i>, and <i>VIM</i>) was determined by RT-qPCR after cells were treated for 48 hours as indicated in <b>A</b> or with MCM. Pooled data for PDAC-185, A6L, 215, 253, and 354 (<i>n</i> ≥ 4 for each cell type). Data are normalized to <i>HPRT1</i>. Eto, etomoxier; Mal, malonate; Met, metformin. <b>C,</b> PDAC-215, 253, and 354 cells were treated with MCM or 20 μmol/L etomoxir for 48 hours and seeded in modified Boyden invasion chambers containing 20% FBS in the lower compartment. The number of invasive cells was analyzed after 16 hours (<i>n</i> = 7–11). <b>D,</b> GFP<sup>+</sup>-Luciferase<sup>+</sup>-PDAC-354 cells were treated with control, MCM, or 20 μmol/L etomoxir for 48 hours and then injected intrasplenically to assess their metastatic capacity (<i>n</i> = 9 mice/group). Representative photographs of liver metastasis (top) and subsequent hematoxylin and eosin staining (bottom). Scale bar, 200 μm. <b>E,</b> Representative OCR profile for PDAC-253 cells treated for 48 hours as indicated (mitochondrial stress test). O, ATP synthase inhibitor oligomycin; F, mitochondrial OXPHOS uncoupler FCCP [carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone]; A+R, complex III inhibitor antimycin A + electron transport change inhibitor rotenone. <b>F,</b> Maximal and ATP-linked respiration (resp) in non-CSC vs. CSC cells. Bars represent pooled data from PDAC-215, 253, and 354, showing individual data points corresponding to each PDX (<i>n</i> = 5–7). <b>G,</b> Representative extracellular acidification rate (ECAR) profile for PDAC-253 cells treated for 48 hours as indicated (glycolysis test). G, glucose; O, ATP synthase inhibitor oligomycin; 2DG, glycolysis inhibitor 2-deoxy-glucose. <b>H,</b> Glycolysis, glycolytic capacity, and glycolytic reserve in adherent (non-CSC) vs. sphere-derived cells (CSC). Bars represent pooled data from PDAC-215, 253, and 354, showing individual data points corresponding to each PDX (<i>n</i> = 4–5). All data are represented as the mean ± SEM. *, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001. See also Supplementary Figs. S1–S3. </p>

Authors

Publication Details

Published
2025-09-02
DOI
https://doi.org/10.1158/0008-5472.30029501
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Figure 1 from PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer

Mariia Yuneva, Petra Jagušt, Jelena Zurkovic, David Barneda et al.
Peroxisome Proliferator-Activated Receptors
article

Figure 1 from PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer

Mariia Yuneva, Petra Jagušt, Jelena Zurkovic, David Barneda, Bruno Sáinz, Patricia Sancho, Beatriz Parejo-Alonso, Laura Ruíz-Cañas, Matthias M. Gaida, Sara Maria David Trabulo, Shanthini Mary Crusz, Pilar Espiau-Romera, Christopher Heeschen, Sara Compte-Sancerni, Sarah Courtois, Pilar Irún, Ulf Schmitz, Laure Penin-Peyta, Ming-Hsin Yang, Ángel Lanas, Meng‐Lay Lin, Alba Royo-García, Jiajia Tang, Quan Zheng, Christoph Thiele, Shenghui Huang, Andrés Gordo-Ortiz
article en

Abstract

<p>Induction of EMT-like phenotype and metabolic switch in PDAC cells upon starvation. <b>A,</b> Representative images illustrating morphologic changes for PDAC-354 cells in response to treatment for 72 hours with the complex I inhibitor metformin (3 mmol/L), the β-oxidation inhibitor etomoxir (20 μmol/L), the complex II inhibitor malonate (5 mmol/L), the pyruvate carrier inhibitor UK5099 (100 μmol/L), or tumor-like conditions [low pH (HCl 50 μmol/L) + low glucose (1 mmol/L) + 3%O<sub>2</sub>]. Scale bar, 50 μm. <b>B,</b> Expression of EMT-associated genes (<i>ZEB1</i>, <i>SNAI1</i>, <i>SNAI2</i>, <i>LOXL2</i>, and <i>VIM</i>) was determined by RT-qPCR after cells were treated for 48 hours as indicated in <b>A</b> or with MCM. Pooled data for PDAC-185, A6L, 215, 253, and 354 (<i>n</i> ≥ 4 for each cell type). Data are normalized to <i>HPRT1</i>. Eto, etomoxier; Mal, malonate; Met, metformin. <b>C,</b> PDAC-215, 253, and 354 cells were treated with MCM or 20 μmol/L etomoxir for 48 hours and seeded in modified Boyden invasion chambers containing 20% FBS in the lower compartment. The number of invasive cells was analyzed after 16 hours (<i>n</i> = 7–11). <b>D,</b> GFP<sup>+</sup>-Luciferase<sup>+</sup>-PDAC-354 cells were treated with control, MCM, or 20 μmol/L etomoxir for 48 hours and then injected intrasplenically to assess their metastatic capacity (<i>n</i> = 9 mice/group). Representative photographs of liver metastasis (top) and subsequent hematoxylin and eosin staining (bottom). Scale bar, 200 μm. <b>E,</b> Representative OCR profile for PDAC-253 cells treated for 48 hours as indicated (mitochondrial stress test). O, ATP synthase inhibitor oligomycin; F, mitochondrial OXPHOS uncoupler FCCP [carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone]; A+R, complex III inhibitor antimycin A + electron transport change inhibitor rotenone. <b>F,</b> Maximal and ATP-linked respiration (resp) in non-CSC vs. CSC cells. Bars represent pooled data from PDAC-215, 253, and 354, showing individual data points corresponding to each PDX (<i>n</i> = 5–7). <b>G,</b> Representative extracellular acidification rate (ECAR) profile for PDAC-253 cells treated for 48 hours as indicated (glycolysis test). G, glucose; O, ATP synthase inhibitor oligomycin; 2DG, glycolysis inhibitor 2-deoxy-glucose. <b>H,</b> Glycolysis, glycolytic capacity, and glycolytic reserve in adherent (non-CSC) vs. sphere-derived cells (CSC). Bars represent pooled data from PDAC-215, 253, and 354, showing individual data points corresponding to each PDX (<i>n</i> = 4–5). All data are represented as the mean ± SEM. *, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001. See also Supplementary Figs. S1–S3. </p>

Openalex Percentile: Top 80%
Peroxisome Proliferator-Activated Receptors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.